Publishing research using ab70324? Please let us know so that we can cite the reference in this datasheet.

ab70324 has been referenced in 1 publication.

  • Syn NL  et al. Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models. Signal Transduct Target Ther 3:9 (2018). PubMed: 29666673

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up